192 related articles for article (PubMed ID: 10623732)
1. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein.
Flint M; Dubuisson J; Maidens C; Harrop R; Guile GR; Borrow P; McKeating JA
J Virol; 2000 Jan; 74(2):702-9. PubMed ID: 10623732
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
3. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.
Owsianka A; Clayton RF; Loomis-Price LD; McKeating JA; Patel AH
J Gen Virol; 2001 Aug; 82(Pt 8):1877-1883. PubMed ID: 11457993
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.
Heile JM; Fong YL; Rosa D; Berger K; Saletti G; Campagnoli S; Bensi G; Capo S; Coates S; Crawford K; Dong C; Wininger M; Baker G; Cousens L; Chien D; Ng P; Archangel P; Grandi G; Houghton M; Abrignani S
J Virol; 2000 Aug; 74(15):6885-92. PubMed ID: 10888628
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.
Flint M; Thomas JM; Maidens CM; Shotton C; Levy S; Barclay WS; McKeating JA
J Virol; 1999 Aug; 73(8):6782-90. PubMed ID: 10400776
[TBL] [Abstract][Full Text] [Related]
7. Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
Gopal R; Jackson K; Tzarum N; Kong L; Ettenger A; Guest J; Pfaff JM; Barnes T; Honda A; Giang E; Davidson E; Wilson IA; Doranz BJ; Law M
PLoS Pathog; 2017 Dec; 13(12):e1006735. PubMed ID: 29253863
[TBL] [Abstract][Full Text] [Related]
8. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
Flint M; Maidens C; Loomis-Price LD; Shotton C; Dubuisson J; Monk P; Higginbottom A; Levy S; McKeating JA
J Virol; 1999 Aug; 73(8):6235-44. PubMed ID: 10400713
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81.
Allander T; Drakenberg K; Beyene A; Rosa D; Abrignani S; Houghton M; Widell A; Grillner L; Persson MAA
J Gen Virol; 2000 Oct; 81(Pt 10):2451-2459. PubMed ID: 10993933
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
[TBL] [Abstract][Full Text] [Related]
13. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
14. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
Drummer HE; Boo I; Maerz AL; Poumbourios P
J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
[TBL] [Abstract][Full Text] [Related]
15. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
[TBL] [Abstract][Full Text] [Related]
17. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
18. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
19. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.
Roccasecca R; Ansuini H; Vitelli A; Meola A; Scarselli E; Acali S; Pezzanera M; Ercole BB; McKeating J; Yagnik A; Lahm A; Tramontano A; Cortese R; Nicosia A
J Virol; 2003 Feb; 77(3):1856-67. PubMed ID: 12525620
[TBL] [Abstract][Full Text] [Related]
20. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
Owsianka AM; Timms JM; Tarr AW; Brown RJ; Hickling TP; Szwejk A; Bienkowska-Szewczyk K; Thomson BJ; Patel AH; Ball JK
J Virol; 2006 Sep; 80(17):8695-704. PubMed ID: 16912317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
